Breast Cancer Liquid Biopsy Trial
Liquid vs Tissue Biopsy Concordance in Samples of 1st Suspected BCa Recurrence/Metastasis and Evaluation of DefineMBC Comprehensive Cancer Profiling Liquid Biopsy LDT
Sponsor: Anthony Magliocco
A observational or N/A phase clinical study on Breast Cancer and Cancer, this trial is ongoing. The trial is conducted by Anthony Magliocco and has accumulated 6 data snapshots since 2020. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
Sep 2024 — Sep 2025 [monthly]
Unknown
Status: Recruiting → Unknown
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Sep 2022 — Jul 2024 [monthly]
Recruiting
-
Dec 2021 — Sep 2022 [monthly]
Recruiting
▶ Show 1 earlier version
-
Sep 2021 — Dec 2021 [monthly]
Recruiting
First recorded
Sep 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Anthony Magliocco
- DHR Health Institute for Research and Development
- Epic Sciences
- Florida Cancer Specialist
- Memorial Healthcare System
- Montefiore Medical Center
- NY Health d/b/a New York Cancer and Blood Specialists
- Northwest Community Healthcare
- Ocala Oncology
- University of Saskatchewan
For direct contact, visit the study record on ClinicalTrials.gov .